Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Radice

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|March 6, 2010
"Waiting and the waiting room: how do you experience them?" emotional implications and suggestions from patients with cancerChiara Catania, Tommaso De Pas, Ida Minchella, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 26, 2021
Economic implications of ACOSOG Z0011 trial application into clinical practice at the European Institute of OncologyDenise Mattar, Antonio Di Filippo, Alessandra Invento, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 22, 2012
Features and prognostic factors of large node-negative non-small-cell lung cancers shifted to stage IIFrancesca Toffalorio, Davide Radice, Lorenzo Spaggiari, et al.
Oncology|January 14, 2010
Safety, tolerability and biological effects of long-term metronomic administration of non-cytotoxic anti-angiogenic agentsCristina Noberasco, Gianluca Spitaleri, Patrizia Mancuso, et al.
Cancers|September 23, 2022
Addressing the Role of Angiogenesis in Patients with Advanced Pancreatic Neuroendocrine Tumors Treated with Everolimus: A Biological Prospective Analysis of Soluble Biomarkers and Clinical OutcomesChiara Alessandra Cella, Francesca Spada, Alfredo Berruti, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 18, 2010
Randomized phase II trial of inhaled budesonide versus placebo in high-risk individuals with CT screen-detected lung nodulesGiulia Veronesi, Eva Szabo, Andrea Decensi, et al.
Leukemia & Lymphoma|June 29, 2010
Rituximab and subcutaneous cladribine in chronic lymphocytic leukemia for newly diagnosed and relapsed patientsPaola Bertazzoni, Cristina Rabascio, Federica Gigli, et al.
Neuroendocrinology|January 21, 2016
Oxaliplatin-Based Chemotherapy in Advanced Neuroendocrine Tumors: Clinical Outcomes and Preliminary Correlation with Biological FactorsFrancesca Spada, Lorenzo Antonuzzo, Riccardo Marconcini, et al.
The Lancet. Neurology|March 12, 2011
Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trialDavide Pareyson, Mary M Reilly, Angelo Schenone, et al.
Oncotarget|April 18, 2018
5'-nucleotidase cN-II emerges as a new predictive biomarker of response to gemcitabine/platinum combination chemotherapy in non-small cell lung cancerFrancesca Toffalorio, Mariacarmela Santarpia, Davide Radice, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|March 6, 2010
"Waiting and the waiting room: how do you experience them?" emotional implications and suggestions from patients with cancerChiara Catania, Tommaso De Pas, Ida Minchella, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 26, 2021
Economic implications of ACOSOG Z0011 trial application into clinical practice at the European Institute of OncologyDenise Mattar, Antonio Di Filippo, Alessandra Invento, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 22, 2012
Features and prognostic factors of large node-negative non-small-cell lung cancers shifted to stage IIFrancesca Toffalorio, Davide Radice, Lorenzo Spaggiari, et al.
Oncology|January 14, 2010
Safety, tolerability and biological effects of long-term metronomic administration of non-cytotoxic anti-angiogenic agentsCristina Noberasco, Gianluca Spitaleri, Patrizia Mancuso, et al.
Cancers|September 23, 2022
Addressing the Role of Angiogenesis in Patients with Advanced Pancreatic Neuroendocrine Tumors Treated with Everolimus: A Biological Prospective Analysis of Soluble Biomarkers and Clinical OutcomesChiara Alessandra Cella, Francesca Spada, Alfredo Berruti, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 18, 2010
Randomized phase II trial of inhaled budesonide versus placebo in high-risk individuals with CT screen-detected lung nodulesGiulia Veronesi, Eva Szabo, Andrea Decensi, et al.
Leukemia & Lymphoma|June 29, 2010
Rituximab and subcutaneous cladribine in chronic lymphocytic leukemia for newly diagnosed and relapsed patientsPaola Bertazzoni, Cristina Rabascio, Federica Gigli, et al.
Neuroendocrinology|January 21, 2016
Oxaliplatin-Based Chemotherapy in Advanced Neuroendocrine Tumors: Clinical Outcomes and Preliminary Correlation with Biological FactorsFrancesca Spada, Lorenzo Antonuzzo, Riccardo Marconcini, et al.
The Lancet. Neurology|March 12, 2011
Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trialDavide Pareyson, Mary M Reilly, Angelo Schenone, et al.
Oncotarget|April 18, 2018
5'-nucleotidase cN-II emerges as a new predictive biomarker of response to gemcitabine/platinum combination chemotherapy in non-small cell lung cancerFrancesca Toffalorio, Mariacarmela Santarpia, Davide Radice, et al.
Pageof 11